Abviris Home

Tumor marker

A blood based entire body screen to find HPV induced cancer early - all within minutes and by using just one drop of blood

Prevo-Check®

Rapid test for detecting HPV16 induced carcinomas early. Easy to use in doctor's practice.
Clinical specificity > 99%

White Papers

Learn more about screening for HPV induced cancer in the white paper series "Guidelines for identifying high-risk patients"

Literature

Find relevant resources about HPV and cancer

previous arrow
next arrow
Slider

Moving from cell to blood based HPV cancer screening.

Abviris offers a new patented generation of Immune Oncology Diagnostics for early detection of HPV induced cancer, allowing a blood based entire body screen within minutes just using one drop of blood.

Learn more about Prevo-Check®

News

Investors Convinced of Potential and Importance of a Novel Cancer Management Concept

Abviris GmbH Obtains Almost 3 Million Euros in Series A Financing Abviris GmbH commenced market entry in Germany after successful test-marketing phase (450 customers, 300,000 € revenues) and, respective clinical trials. Initial positioning is targeting screening for HPV induced tumours of head and neck and the anogenital region. Funds raised in round A reveal that …

Tumour marker for the early detection and therapy of HPV-induced anal cancer for HIV+ patients

A pilot study has compared serum samples of HIV+ patients before and after treatment of an HPV induced anal carcinoma using the Prevo-Check®. Prevo-Check® has been confirmed as a high quality test for the early detection and therapy of HPV induced anal cancer for HIV+ patients. Study participants showing a high Prevo-Check® result developed anal …

Abviris and Mayo Clinic sign cooperation for research into HPV induced cancer diagnostics

Rochester, MN (USA) / Ahrensburg, Germany: Mayo Clinic and Abviris Deutschland GmbH have successfully signed a cooperation agreement for preclinical research into the diagnostics of HPV induced cancer. Mayo Clinic is one of the leading healthcare and medical research centers of the world. HPV and cancer HPV is responsible for 5% of all cancers, men …

Events

Sep
13
Fri
3. Hamburger Symposium Seattle Study Club @ Hotel Gastwerk
Sep 13 all-day

SSC Fortbildung:

3. Hamburger Symposium – Parodontitis und systemische Erkrankungen.

9:00 bis ca 17:00 Uhr

Dermapraxis Berlin @ Umweltforum Auferstehungskirche
Sep 13 – Sep 15 all-day

Der Kongress für ambulante Dermatologie in Zusammenarbeit mit dem BVDD.  Im Vortrag von Dr. Ralf Hilfrich "Kombinierte Vorsorge aus HPV-Impfung und serologischer Diagnostik" erfahren Sie mehr zu den Möglichkeiten der Früherkennung von HPV16 induzierten Tumoren. Der Vortrag findet am 13.09. nachmittags statt. Wir freuen uns auf Ihren Besuch an unserem Messestand.

Oct
10
Thu
50. Kongress der Deutschen Gesellschaft für Wehrmedizin und Wehrpharmazie e. V. @ KONGRESSHALLE am Zoo Leipzig
Oct 10 – Oct 12 all-day

Besuchen Sie den Stand von Abviris Deutschland GmbH. Wir freuens uns auf das Gespräch mit Ihnen.

Die Veranstaltung ist bei der Sächsischen Landesärztekammer als zertifizierte Fortbildung beantragt. Bitte Barcodes nicht vergessen.